David William Pook

David William Pook

Monash University - Clayton / Australia
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 114456
Monash University
person_outline David William Pook's MOST POPULAR ARTICLES
1-) Nivolumab plus cabozantinib versus sunitinib for advanced renal-cell carcinomaTK Choueiri, T Powles, M Burotto, B Escudier, MT Bourlon, B Zurawski, ...New England Journal of Medicine 384 (9), 829-841, 202112052021
2-) Enzalutamide with standard first-line therapy in metastatic prostate cancerID Davis, AJ Martin, MR Stockler, S Begbie, KN Chi, S Chowdhury, ...New England Journal of Medicine 381 (2), 121-131, 201911952019
3-) Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised …RJ Motzer, BI Rini, DF McDermott, OA Frontera, HJ Hammers, ...The Lancet Oncology 20 (10), 1370-1385, 20195082019
4-) Phase III trial of PROSTVAC in asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancerJL Gulley, M Borre, NJ Vogelzang, S Ng, N Agarwal, CC Parker, DW Pook, ...Journal of Clinical Oncology 37 (13), 1051-1061, 20192472019
5-) Niraparib and abiraterone acetate for metastatic castration-resistant prostate cancerKN Chi, D Rathkopf, MR Smith, E Efstathiou, G Attard, D Olmos, JY Lee, ...Journal of Clinical Oncology 41 (18), 3339-3351, 20231822023